We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toTFDA-Town-Hall

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.


TFDA Town Hall

    Session Chair(s)
      Shou-Mei  Wu, PhD

      Shou-Mei Wu, PhD

      • Director General
      • TFDA, Taiwan
    The safety, quality, and effectiveness of drugs are closely entwined with our daily lives and health. The Taiwan Food and Drugs Administration (TFDA) has played a crucial role in promoting public health and continued to enhance a comprehensive drugs safety management system. During this forum, TFDA will share the updated information of regulatory management of drug development, challenges of MRCT implementation, the application of real world evidence, and innovative biotechnological medicine.
    Learning Objective : To introduce adjustments to the TFDA’s system in response to new and innovative drugs in global MRCTs. A successful story based on transparency and efficiency with a predictable timeline to promote early access to effective, safe, and high-quality pharmaceutical products in Taiwan and China.
    Speaker(s)
      Shou-Mei  Wu, PhD

      TFDA Perspective on Regulatory Management of Drug Development

      Shou-Mei Wu, PhD

      • Director General
      • TFDA, Taiwan
      James Chih-Hsin  Yang, MD, PhD

      Global Challenges in Conducting MRCT and Interpreting Data

      James Chih-Hsin Yang, MD, PhD

      • Director, Department of Oncology
      • NTU Hospital, Taiwan
      Churn-Shiouh  Gau, PhD, MS

      Using Real World Evidence in Regulatory Decision-Making

      Churn-Shiouh Gau, PhD, MS

      • Executive Director
      • Center For Drug Evaluation, Taiwan, Taiwan
      Annie Tsu-Hui  Liu

      The Development of Pharmaceutical Industry in Taiwan

      Annie Tsu-Hui Liu

      • Director, Office of Science and Technology
      • Executive Yuan, Taiwan